Akebia Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement ...Middle East

CAMBRIDGE, Mass., May 22, 2023 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it has received a formal notice from The Nasdaq Stock Market (Nasdaq)...

Hence then, the article about akebia therapeutics regains compliance with nasdaq minimum bid price requirement was published today ( Tuesday 23/05/2023 - 12:20 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Akebia Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement )

Also on site :

• 2010s Rock Band Announces Tour for 10th Anniversary of Debut Album
• Nuclear neighbors and a two‑front threat: Why India needs a rocket force
• Greenland hit by power outage, strong winds in wake of US tensions easing